Have a personal or library account? Click to login
Assessment of ocrelizumab impact on neurofilament levels in multiple sclerosis patients Cover

Assessment of ocrelizumab impact on neurofilament levels in multiple sclerosis patients

Revista Romana de Medicina de Laborator
Volume 32 (2024): Issue 3 (July 2024)
By: Smaranda Maier,  Adina Huțanu,  Laura Bărcuțean,  Emanuela Sărmășan and  Rodica Bălașa  
Open Access
|Jul 2024

Authors

Smaranda Maier

Department of Neurology, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania
Neurology 1 Clinic, Mures County Emergency Clinical Hospital, Targu Mures, Romania

Adina Huțanu

adina.hutanu@umfst.ro

Department of Laboratory Medicine, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania
Central Laboratory, Mures County Emergency Clinical Hospital, Targu Mures, Romania
Center for Advanced Medical and Pharmaceutical Research, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania

Laura Bărcuțean

Department of Neurology, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania
Neurology 1 Clinic, Mures County Emergency Clinical Hospital, Targu Mures, Romania

Emanuela Sărmășan

Neurology 1 Clinic, Mures County Emergency Clinical Hospital, Targu Mures, Romania

Rodica Bălașa

Department of Neurology, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania
Neurology 1 Clinic, Mures County Emergency Clinical Hospital, Targu Mures, Romania
DOI: https://doi.org/10.2478/rrlm-2024-0019 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Journal RSS Feed
Language: English
Page range: 245 - 254
Submitted on: Apr 11, 2024
|
Accepted on: Apr 23, 2024
|
Published on: Jul 31, 2024
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
neurofilament light chain,
ocrelizumab,
primary progressive multiple sclerosis,
relapsing-remitting multiple sclerosis
Related subjects:
Life sciences,
Molecular biology,
Biochemistry,
Human biology,
Microbiology and virology

© 2024 Smaranda Maier, Adina Huțanu, Laura Bărcuțean, Emanuela Sărmășan, Rodica Bălașa, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 32 (2024): Issue 3 (July 2024)Next article